Procter & Gamble Health

5,761.00
-93.00
(-1.59%)
Market Cap
9,562.90 Cr
EPS
141.22
PE Ratio
37.38
Dividend Yield
4.44 %
Industry
Healthcare
52 Week High
6,175.50
52 Week Low
4,863.00
PB Ratio
18.11
Debt to Equity
0.02
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,677.60
#1 4,02,512.43
35.11
#1 52,041.20
12.06
#1 10,980
-18.99
49.60
6,899.50
1,83,160.05
83.20
9,360.00
0.89
2,117
23.05
67.24
1,516.50
1,22,488.89
23.68
28,409.50
7.12
5,291
30.28
52.75
3,364.50
1,13,869.97
58.56
11,317.00
11.59
2,054
10.91
59.08
1,292.00
1,07,826.58
19.45
33,741.20
12.36
5,725
21.14
49.51
1,008.75
1,01,503.85
21.53
22,573.80
13.82
3,977
-0.19
69.48
2,454.00
1,01,283.63
49.11
12,207.40
19.57
1,925
-10.91
49.97
1,989.70
90,868.70
27.22
22,192.10
#1 19.94
3,024
#1 112.49
47.26
35,085.00
74,553.18
53.31
6,409.15
10.80
1,417
27.83
71.69
1,181.50
68,621.71
#1 19.42
31,378.10
17.55
3,366
-0.50
55.14
Forecast
Actual
Growth Rate
Revenue Growth
-6.50 %
Net Income Growth
-12.42 %
Cash Flow Change
-3.28 %
ROE
22.19 %
ROCE
20.53 %
EBITDA Margin (Avg.)
0.25 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2020
2021
2022
2023
2024
2025
Revenue
963
1,017
722
873
1,425
1,027
1,128
1,248
1,167
934
Expenses
856
877
621
701
1,041
763
847
905
845
616
EBITDA
107
140
101
173
384
264
281
343
322
318
Operating Profit %
9 %
12 %
11 %
17 %
23 %
24 %
24 %
26 %
27 %
34 %
Depreciation
23
25
19
21
30
30
27
28
27
17
Interest
0
0
0
0
0
1
0
1
1
0
Profit Before Tax
83
115
99
158
355
233
253
314
273
312
Tax
30
36
38
56
101
57
61
85
72
78
Net Profit
54
79
61
102
254
177
193
230
201
234
EPS in ₹
32.30
47.70
56.60
505.27
153.00
107.00
116.00
138.00
121.00
141.22

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2020
2021
2022
2023
2024
Total Assets
784
879
991
1,760
1,176
986
888
1,101
794
Fixed Assets
132
111
115
104
101
104
112
144
129
Current Assets
572
636
752
1,534
954
727
608
796
524
Capital Work in Progress
7
30
9
17
22
39
41
33
6
Investments
42
28
70
0
0
0
0
0
0
Other Assets
603
711
797
1,639
1,053
843
736
925
660
Total Liabilities
784
879
991
1,760
1,176
986
888
1,101
794
Current Liabilities
165
186
225
193
227
239
232
304
219
Non Current Liabilities
27
29
33
27
42
44
40
46
37
Total Equity
592
664
733
1,540
906
704
617
751
538
Reserve & Surplus
575
647
717
1,524
890
687
600
734
522
Share Capital
17
17
17
17
17
17
17
17
17

Cash Flow

Cash Flow
2015
2016
2017
2018
2020
2021
2022
2023
2024
Net Cash Flow
4
17
-16
1,109
-483
-172
-145
116
-197
Investing Activities
-68
-75
-48
1,270
165
-32
-26
-22
-7
Operating Activities
84
107
54
-130
235
247
170
236
228
Financing Activities
-12
-15
-22
-30
-883
-387
-289
-99
-418

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 11 15 440 0.00 230 130 52.5 95 260 0.00
Dividend Yield (%) 1.05 1 11.91 0.00 3.71 3.25 1.12 2.02 5.05 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
01 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
01 Aug 2025 5,921.00 5,854.00
29 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
29 May 2025 5,311.80 5,848.00
21 Feb 2025 DIVIDEND Dividend
₹ 80.00 /share
21 Feb 2025 5,365.15 5,290.50
12 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Feb 2025 5,287.05 5,365.15
05 Dec 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Dec 2024 5,234.60 5,602.60
29 Nov 2024 DIVIDEND Dividend
₹ 60.00 /share
28 Nov 2024 5,373.45 5,189.95
04 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
04 Nov 2024 5,519.30 5,287.00
14 Feb 2024 DIVIDEND Dividend
₹ 150.00 /share
14 Feb 2024 5,328.50 5,275.85
14 Feb 2024 DIVIDEND Dividend
₹ 50.00 /share
14 Feb 2024 5,328.50 5,275.85
30 Nov 2023 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Nov 2023 5,088.15 5,145.70
24 Nov 2023 DIVIDEND Dividend
₹ 50.00 /share
23 Nov 2023 5,343.35 5,155.15
13 Feb 2023 DIVIDEND Dividend
₹ 45.00 /share
13 Feb 2023 4,096.95 4,690.90
23 Nov 2022 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Nov 2022 4,290.30 4,125.60
17 Nov 2022 DIVIDEND Dividend
₹ 11.50 /share
15 Nov 2022 4,170.45 4,240.40
13 May 2022 DIVIDEND Dividend
₹ 41.00 /share
12 May 2022 4,457.35 4,407.50
05 Nov 2021 DIVIDEND Dividend
₹ 40.00 /share
02 Nov 2021 5,439.30 5,444.20
05 Nov 2021 DIVIDEND Dividend
₹ 90.00 /share
02 Nov 2021 5,483.15 5,444.20
06 May 2019 CHANGE OF NAME Change Of Name
NA
06 May 2019 3,611.20 3,611.20

Announcements

Announcement under Regulation 30 (LODR)-Change in Management6 days ago
Board Meeting Intimation for Intimation Of Board Meeting To Be Held On August 1 20257 days ago
Closure of Trading Window7 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJun 17, 2025
Analysts/Institutional Investors - PresentationJun 16, 2025
Change In Senior Management Personnel Of The Company Jun 11, 2025
Communication In Respect Of Deduction Of Tax At Source (TDS) On The Amount Of Dividend Income From Procter & Gamble Health LimitedJun 09, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
Appointment Of Secretarial AuditorsMay 29, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
Corporate Action-Board approves DividendMay 29, 2025
Financial Results For The Year Ended March 312025May 29, 2025
Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
Board Meeting Outcome for Outcome On Financial Results And DividendMay 29, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 14, 2025
Appointment Of Mr. Sharad Tyagi (DIN- 00371842) And Ms. Krishna Sarma (DIN00016115) As Non-Executive Independent Directors Of The Company For A Period Of Five YearsApr 10, 2025
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotApr 10, 2025
Closure of Trading WindowMar 26, 2025
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On May 29 2025Mar 26, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 10, 2025
Integrated Filing (Financial)Feb 18, 2025
Communication With Respect To Tds On Dividend Income Declared By The CompanyFeb 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 12, 2025
Appointment Of Chairperson Of The BoardFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateFeb 12, 2025
Corporate Action-Board approves DividendFeb 12, 2025
Unaudited Financial ResultsFeb 12, 2025
Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25Feb 12, 2025
Board Meeting Outcome for Unaudited Financial Result And Interim Dividend For The FY 2024-25Feb 12, 2025
Update on board meetingJan 31, 2025
Intimation Regarding Change Of The Financial Year Of The CompanyJan 23, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 09, 2025
Board Meeting Intimation for Intimation Of Board Meeting Scheduled To Be Held On February 12 2025Dec 27, 2024
Closure of Trading WindowDec 27, 2024
Change In Senior Management Personnel Of The CompanyDec 06, 2024
Shareholder Meeting / Postal Ballot-Outcome of AGMDec 06, 2024
Shareholder Meeting / Postal Ballot-Scrutinizer''s ReportDec 06, 2024
Proceedings Of The 57Th Annual General Meeting Of Shareholders Held On December 5, 2024Dec 05, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 21, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateNov 20, 2024
Reg. 34 (1) Annual Report.Nov 13, 2024
Business Responsibility and Sustainability Reporting (BRSR)Nov 13, 2024
Annual Report And Notice Calling The 57Th Annual General Meeting Of The Company For The Financial Year Ended June 30, 2024Nov 13, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 04, 2024
For The Quarter Ended September 30,2024Nov 04, 2024
Board Meeting Outcome for Unaudited Financial ResultsNov 04, 2024
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate CertificateOct 29, 2024

Technical Indicators

RSI(14)
Neutral
57.76
ATR(14)
Less Volatile
154.60
STOCH(9,6)
Neutral
48.89
STOCH RSI(14)
Oversold
7.07
MACD(12,26)
Bearish
-27.24
ADX(14)
Strong Trend
27.47
UO(9)
Bearish
51.94
ROC(12)
Downtrend And Accelerating
-0.96
WillR(14)
Neutral
-52.25

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal Quant Fund Direct-Growth
0.00%
-2373
-0.93%
-0.94%
Nippon India Small Cap Fund Direct- Growth
0.62%
634
0.02%
-0.01%
UTI Healthcare Fund Direct-Growth
4.34%
520
0.44%
0.69%
HDFC BSE 500 Index Fund Direct - Growth
0.02%
2
0.00%
0.00%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.36%
1
0.04%
0.03%
Mirae Asset Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Sundaram Long Term Micro Cap Tax Advantage Fund Series III Direct-Growth
2.76%
0
0.12%
-0.02%
HDFC Retirement Savings Fund - Hybrid Equity Plan Direct-Growth
0.42%
0
0.04%
0.03%
ICICI Prudential Bharat Consumption Fund Direct - Growth
0.50%
0
0.05%
0.02%
ICICI Prudential MNC Fund Direct - Growth
0.31%
0
0.02%
0.04%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.81%
0
0.07%
0.00%
ICICI Prudential Smallcap Fund Direct Plan-Growth
2.42%
0
0.10%
0.00%
Aditya Birla Sun Life MNC Fund Direct-Growth
1.09%
0
0.05%
0.03%
Motilal Oswal Nifty Microcap 250 Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
DSP Healthcare Fund Direct - Growth
3.08%
0
0.31%
0.37%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct - Growth
0.00%
0
0.00%
0.00%
Sundaram Long Term Micro Cap Tax Advantage Fund Series IV Direct - Growth
2.74%
0
0.12%
0.00%
Sundaram Long Term Micro Cap Tax Advantage Fund Series V Direct - Growth
3.00%
0
0.14%
0.02%
Sundaram Long Term Micro Cap Tax Advantage Fund Series VI Direct - Growth
2.89%
0
0.14%
0.00%
Sundaram Long Term Tax Advantage Fund Series III Direct - Growth
3.01%
0
0.15%
0.02%
Sundaram Long Term Tax Advantage Fund Series IV Direct - Growth
3.26%
0
0.17%
0.02%
Sundaram Small Cap Fund Direct-Growth
0.00%
0
0.00%
0.00%
Tata India Pharma & Healthcare Fund Direct-Growth
0.75%
0
0.08%
0.05%
Aditya Birla Sun Life Pharma & Healthcare Fund Direct-Growth
1.34%
0
0.16%
0.14%